Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Formoterol (12mcg) + Glycopyrrolate (12.5mcg) Rota Capsule
Dosage Form : Rota cap
Packaging Type : in a Bottle
Packaging : 30 Capsules
Price : ₹1/-
Formoterol 12mcg + Glycopyrrolate 12.5mcg rota capsule is a dual-action bronchodilator formulation used for the effective management of chronic obstructive pulmonary disease (COPD) and bronchospasm.
Formoterol provides long-acting beta-2 adrenergic bronchodilation, relaxing airway smooth muscles, while Glycopyrrolate acts as a long-acting muscarinic antagonist, reducing airway constriction and improving airflow.
This rotacap is commonly prescribed for maintenance therapy in COPD, chronic bronchitis, and emphysema, helping reduce breathlessness, wheezing, and the frequency of exacerbations.
With clinically proven efficacy, dual-mechanism action, and convenient once-daily dosing, this formulation strengthens a respiratory therapy product portfolio and supports consistent patient demand for pulmonary care.
Common side effects may include dry mouth, throat irritation, cough, tremors, headache, or mild dizziness. Rarely, urinary retention, palpitations, or cardiovascular effects may occur in sensitive patients.
Flutialfa G 12 Rota Capsule is indicated for the maintenance treatment of COPD, including chronic bronchitis and emphysema. It helps in controlling symptoms, improving lung function, and reducing exacerbations, as prescribed by a healthcare professional.
For inhalation use only. Use under strict medical supervision. Not intended for acute bronchospasm relief. Follow proper inhalation technique and clean the inhaler as directed.
Store below 25°C in a cool, dry place. Protect from direct sunlight and moisture. Keep out of reach of children.
Composition : Fluticasone Furoate (27.5mcg) + Azelastine (140mcg)
Composition : Fluticasone Furoate (50mcg)
Composition : Fluticasone Furoate (27.5mcg)
Composition : Fluticasone Propionate (0.005% w/v)
Composition : Mometasone (50mcg)
Composition : Xylometazoline (0.1% w/v)
Composition : Xylometazoline (0.05% w/v)
Composition : Sodium Chloride I.P. 0.65% w/v + Benzalkonium Chloride Solution I.P. 0.02% w/v Nasal Drop
Composition : Mometasone Furoate (50mcg) + Azelastine Hydrochloride (140mcg) Nasal Spray
Composition : Calcitonin 200IU Nasal spray
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation